Search the Newsreel

Is Docebo Inc (DCBO) a Bargain After 4.4% Drop? GF Value Says Undervalued

Docebo Inc (DCBO) shares recently dropped 4.4%, bringing its price to $19.48, significantly below its GF Value™ estimate of $60.51, suggesting it is undervalued. Despite the undervaluation and a strong growth potential (9/10 GF Score™), a "Possible Value Trap" warning indicates potential challenges and …

Teladoc (TDOC) Gains As Market Dips: What You Should Know

Teladoc (TDOC) ended the recent trading session at $9.65, demonstrating a +2.33% change from the preceding day's closing price. This change outpaced the S&P 500's 0.19% loss on the day. Meanwhile, the Dow lost 0.59%, and the Nasdaq, a tech-heavy index, lost 0.05%. Shares …

ATB Cormark Capital Markets Lowers Docebo (NASDAQ:DCBO) Price Target to $35.00

ATB Cormark Capital Markets has lowered its price target for Docebo (NASDAQ:DCBO) from $36.00 to $35.00, while maintaining an "outperform" rating. This new target suggests a potential upside of 82.6% from the current share price. Docebo's stock recently fell by 6.0% to $19.16, and …

Perdoceo Education expects $230M–$236M adjusted operating income for 2025 as student enrollments rise 17%

Perdoceo Education (PRDO) has raised its 2024 adjusted diluted EPS guidance to $2.82 - $2.87 from $2.70 - $2.80 and expects 2025 adjusted operating income to be between $230 million and $236 million. This positive outlook is driven by a 17% expected increase in …

Should You Investigate DocuSign, Inc. (NASDAQ:DOCU) At US$52.74?

This article examines DocuSign, Inc. (NASDAQ:DOCU) and discusses whether it represents an attractive investment opportunity at its current share price of US$52.74. It likely delves into the company's financials, future prospects, and market valuation to help potential investors make an informed decision.

Healthpeak Properties and Brookfield Form a $2.1 Billion Strategic Joint Venture

DENVER & NEW YORK, July 20, 2026--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak") and Brookfield Asset Management (NYSE: BAM, TSX: BAM) ("Brookfield"), today announced the formation of a long-term strategic capital partnership through a joint venture involving a portfolio of outpatient medical buildings across …

Docebo Inc. (DCBO) sets US$70,000,000 issuer bid at US$20.40

Docebo Inc. (DCBO) has announced a substantial issuer bid to repurchase up to US$70,000,000 of its common shares at US$20.40 per share for cancellation. Intercap Inc., a major shareholder, intends to participate to maintain at least its current ownership percentage. This move could potentially …

Enterprise value to EBIT forward of Perdoceo Education Corporation – FWB:CE1

This article provides financial information for Perdoceo Education Corporation (CE1) on the Frankfurt Stock Exchange, specifically focusing on its Enterprise Value to EBIT forward metric. The content indicates that the market was closed and no trades were made at the time of publication, offering …

DocuSign stock falls as cautious outlook overshadows earnings beat

DocuSign's stock dropped 6% despite exceeding Q1 revenue and earnings estimates, as its forward guidance failed to signal stronger accelerating growth. While the company highlighted the expansion of its AI-powered Intelligent Agreement Management (IAM) platform and strong profitability, analysts remained cautious, noting that the …

Docebo (DCBO) Q1 2025 earnings summary

Docebo (DCBO) released its Q1 2025 earnings, reporting $57.3M in revenue, an 11% year-over-year increase, with subscription revenue comprising 95% of the total. The company exceeded guidance for revenue and profitability, driven by AI-enhanced products and strategic customer acquisitions. Despite macroeconomic headwinds leading to …

Docebo Launches US$70 Million Share Buyback and Reports Strong Preliminary Q2 2026 Results

Docebo (TSE:DCBO) has announced a US$70 million share buyback bid at US$20.40 per share, representing about 13.8% of its outstanding stock. This move, supported by major shareholder Intercap Inc., aims to deliver immediate value to shareholders as management believes the current market price undervalues …

Technical Reactions to DCBO Trends in Macro Strategies

This article analyzes Docebo Inc. (NASDAQ: DCBO) using AI models, highlighting a near-term weak sentiment that could challenge mid-term strength, despite a broader long-term weak bias. A breakout is noted, suggesting potential for higher levels if sustained, with no resistance above the current price. …

Docebo Announces up to $70 Million Substantial Issuer Bid, Reports Preliminary Q2 Results

Docebo announced a substantial issuer bid to purchase for cancellation up to $70 million of its common shares. Concurrently, the company reported preliminary second-quarter results, expecting revenue between $51.0 million and $51.2 million, indicating a 20-21% year-over-year increase, and subscription revenue between $48.2 million …

Docebo Sees 2Q Adjusted Ebitda $10.9M-$11.1M >DCBO.T

Docebo anticipates its Second Quarter Adjusted Ebitda to be between $10.9 million and $11.1 million. This financial outlook provides insight into the company's expected profitability for the quarter.

3 Schools Stocks Managing Through Education Market Headwinds

The Zacks Schools industry faces regulatory scrutiny, funding uncertainty, and rising costs, but demand for healthcare and skilled trades education, coupled with flexible learning and employer partnerships, offers a favorable medium-term outlook. Perdoceo Education Corporation (PRDO), Lincoln Educational Services Corporation (LINC), and American Public …

Enterprise value to EBITDA forward of DocuSign, Inc. – XETR:DS3

This article provides financial information for DocuSign, Inc. (DS3) on the Deutsche Borse Xetra, specifically focusing on its enterprise value to EBITDA forward. It indicates that the market was closed with no trades at the time of publication and gives an overview of the …

Docebo Inc. Announces Substantial Issuer Bid, Preliminary Unaudited Second Quarter 2026 Financial Results, Initial Q3-2026 and Revised FY2026 Guidance

Docebo Inc. announced a substantial issuer bid to repurchase up to US$70 million of its common shares at US$20.40 per share, citing that the current trading price does not fully reflect the company's value. The company also released preliminary unaudited Q2 2026 financial results, …

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Movin

ManpowerGroup reported strong Q2 earnings, surpassing analyst estimates with 99 cents per share in adjusted earnings and $4.86 billion in revenue. This positive performance led to a 5.8% jump in its shares. Several other companies, including Docebo and Zentalis Pharmaceuticals, also saw significant stock …

Stocks in play: Docebo Inc.

Docebo Inc. announced a substantial issuer bid to repurchase up to US$70,000,000 of its common shares at US$20.40 per share. Following this announcement, Docebo Inc. shares (T.DCBO) saw a significant increase in trading, rising by $2.36 to $28.32. This move indicates the company's confidence …

Docebo announces $70m share buyback, reports Q2 results

Docebo Inc. (NASDAQ:DCBO; TSX:DCBO) has announced a substantial issuer bid to repurchase up to $70 million of its common shares at a 10% premium to the current stock price, funded by cash and a credit facility drawdown. The company also reported preliminary unaudited Q2 …

Docebo (NASDAQ: DCBO) unveils US$70M issuer bid at US$20.40

Docebo Inc. (NASDAQ: DCBO) has announced a substantial issuer bid to repurchase up to US$70 million of its common shares at US$20.40 per share, representing approximately 13.8% of outstanding shares. The company will fund the buyback using cash on hand and a draw from …

Teladoc Health (TDOC) Faces Fresh Growth Concerns, Is It Still Overvalued?

Teladoc Health (TDOC) is facing new growth concerns regarding flat sales and declining revenue per user, despite a recent surge in its stock price. While one analysis suggests the stock is 28% overvalued with a fair value of $7.40, another view using a sales …

Amdocs Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh

This article provides financial information for Amdocs Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (D2OX34) on the BMFBOVESPA exchange, specifically highlighting its price to earnings forward. The market is currently closed, with no trades observed. The data is presented through the TradingView …

Perdoceo Education Drops 7.7% Amid Sector-Wide Selling

Perdoceo Education Corporation experienced a 7.7% drop, closing at $33.53, due to a broad selloff affecting education and training services stocks. This decline was not specific to Perdoceo, as several of its sector peers also saw significant losses, suggesting a widespread rotation out of …

How (DOCU) Movements Inform Risk Allocation Models

This article analyzes Docusign Inc. (NASDAQ: DOCU) movements, indicating strong near and mid-term sentiment but a weak long-term outlook. It identifies a breakout with compelling upside potential and no resistance above the current price. The article outlines three AI-generated institutional trading strategies (Position, Momentum …

Teladoc Health to Announce Second Quarter 2026 Financial Results

Teladoc Health Inc. will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after the market closes. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the results, with details provided for both …

Teladoc (TDOC) Stock May Be 39% Below Fair Value As Insurance Expansion Grows

Teladoc Health (TDOC) stock appears undervalued, with valuation checks suggesting it trades at a discount of about 39% below its intrinsic value. Despite a 94% decline over the past five years, the Discounted Cash Flow (DCF) model and sales-based multiples indicate that a recent …

A Look at Docusign Inc (DOCU) After 3.6% Gain -- GF Value $73.23 vs Price $51.16

Docusign Inc (DOCU) shares recently rose 3.6%, trading at $51.16, which is notably below its GF Value™ of $73.23, suggesting it is significantly undervalued. While the company shows strong financial strength and growth potential, profitability and stock momentum are concerns, further compounded by recent …

Teladoc Health to Release Q2 Results After Market Close

Teladoc Health (NYSE: TDOC) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after market close. The company will host a conference call at 5:00 p.m. ET on the same day to review the results, with U.S. participants …

Penny Stocks To Watch In July 2026

This article identifies three penny stocks—DocGo (DCGO), Intrusion (INTZ), and Phunware (PHUN)—to watch in July 2026, highlighting their financial health, operational challenges, and growth prospects. DocGo, a mobile healthcare provider, shows revenue growth despite unprofitability. Intrusion, a cybersecurity firm, is debt-free but faces liquidity …

Price to book forward of DocuSign, Inc. – NASDAQ:DOCU

The article provides financial data for DocuSign, Inc. (NASDAQ: DOCU), specifically its forward price-to-book ratio. It mentions that the market was closed at the time of viewing and lists various financial tools and data provided by TradingView and its partners.

Q1 Earnings Highs And Lows: Amdocs (NASDAQ:DOX) Vs The Rest Of The IT Services & Other Tech Stocks

Healthpeak finishes a cent shy of its yearly high, with volume still below confirmation level

DOC gained 10.2% in the latest week and now sits at 99.8% of its 52-week range, but the move came on 0.9x average volume and with activity pressure cooling from recent levels.

INTP Forecast — Price Target — Prediction for 2027

DCBO Forecast — Price Target — Prediction for 2027

Proyeksi INTP — Target Harga untuk 2027